Filtered by:
18 Programs
-
Oncology Today
Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer
-
-
W
-
W
-
-
W
-
W
-
-
Year in Review
Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Prostate Cancer
-
-
A
-
S
-
A
-
-
A
-
S
-
A
+1 more module
-
-
Rapid Case Review
Investigators Provide Perspectives on Actual Cases of Metastatic Bladder Cancer
-
-
C
-
F
-
M
-
C
-
-
C
-
F
-
M
-
C
+2 more modules
-
-
Cancer Conference Update
ESMO Congress 2025 Review — Urothelial Bladder Cancer
-
-
T
-
T
-
-
T
-
T
-